Advisory Research Inc Axonics, Inc. Transaction History

Advisory Research Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$49.38 - $63.75 $327,932 - $423,363	6,641 Added 144.31%	11,243 $699,000
Q3 2023 Nov 13, 2023	BUY	$48.64 - $62.51 $223,841 - $287,671	4,602 New	4,602 $258,000
Q1 2023 May 12, 2023	SELL	$52.6 - $67.34 $523,948 - $670,773	-9,961 Reduced 41.65%	13,955 $761,000
Q4 2022 Feb 13, 2023	SELL	$59.56 - $76.6 $440,922 - $567,069	-7,403 Reduced 23.64%	23,916 $1.5 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $123,860 - $166,942	-2,137 Reduced 6.39%	31,319 $2.21 Million
Q2 2022 Aug 17, 2022	SELL	$39.5 - $64.42 $1.25 Million - $2.04 Million	-31,690 Reduced 48.64%	33,456 $1.9 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $1.03 Million - $1.48 Million	23,616 Added 56.86%	65,146 $4.08 Million
Q4 2021 Feb 11, 2022	SELL	$50.01 - $73.35 $2.03 Million - $2.98 Million	-40,673 Reduced 49.48%	41,530 $2.33 Million
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $106,222 - $141,116	1,794 Added 2.23%	82,203 $5.35 Million
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $133,973 - $174,408	2,607 Added 3.35%	80,409 $5.1 Million
Q1 2021 May 12, 2021	BUY	$49.14 - $59.89 $1.43 Million - $1.75 Million	29,182 Added 60.02%	77,802 $4.66 Million
Q4 2020 Feb 12, 2021	SELL	$42.19 - $51.5 $71,554 - $87,344	-1,696 Reduced 3.37%	48,620 $2.43 Million
Q3 2020 Nov 12, 2020	BUY	$35.33 - $51.04 $1.78 Million - $2.57 Million	50,316 New	50,316 $2.57 Million

221

42M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.